RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - Epidemiologia e nuove prospettive di prevenzione delle infezioni respiratorie acute
• 2 - Definizione del profilo epidemiologico delle gastroenteriti virali nella prospettiva dell'introduzione di nuove vaccinazioni
• 3 - Infezioni respiratorie: epidemiologia molecolare, cross-protection e impatto delle strategie preventive
• 4 - INFEZIONE DEL CANE DA CORONAVIRUS PANTROPICO: ASPETTI EPIDEMIOLOGICI, PATOGENETICI E MOLECOLARI
• 5 - NECESSITA' DI SORVEGLIANZA VIROLOGICA ED IMMUNOLOGICA NELLA POPOLAZIONE ITALIANA NELLA FASE FINALE DEL PROCESO DI ERADICAZIONE GLOBALE DELLA POLIOMIELITE
• 6 - Strategie vaccinali e modelli matematici.
• 7 - Impatto della vaccinazione sull'epidemiologia del papillomavirus umano (HPV)
• 8 - Approcci vaccinali innovativi per il controllo delle infezioni erpetiche e papillomatose sessualmente trasmesse
• 9 - Un modello integrato di valutazione e gestione del rischio di Infezione Tubercolare e di Tubercolosi in fase attiva in popolazioni socialmente disagiate ("homeless") nella città di Roma.
• 10 - Eziopatogenesi del sarcoma di Kaposi: ruolo dello Human Herpesvirus 8 e di altri co-fattori potenzialmente coinvolti.

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • IGIENE GENERALE E APPLICATA

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
• HUMAN NECESSITIES
  • MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (bringing into special physical form A61J [N: mechanical aspects]; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; compounds per se C01, C07, C08, C12N; soap compositions C11D; micro-organisms per se C12N) [C0203]

Classificazione geografica

• Regione: Sardegna

Bibliografia

Center for disease and prevention Sexually trasmitted disease surveillance 2002.Atlanta GA: US Department of Health and Human services ,September 2003
The epidemiology of human papillomavirus infections.
J Clin Virol. 2005 Mar;32 Suppl:16-24
4. Pagliusi SR, Teresa Aguado M. Efficacy and other milestones for human papillomavirus vaccine introduction. Vaccine. 2004 Dec 16;23(5):569-78.
Gagnon S, Hankins C, Tremblay C, Pourreaux K, Forest P, Rouah F, Coutlee F; TheCanadian Women's HIV Study Group, Francois Coutlee.
Polymorphism of human papillomavirus type 31 isolates infecting the genital tract of HIV-seropositive and HIV-seronegative women at risk for HIV infection. J Med Virol. 2005 Feb;75(2):213-21.
Ferreccio C, Prado RB, Luzoro AV, Ampuero SL, Snijders PJ, Meijer CJ, Vaccarella SV, Jara AT, Puschel KI, Robles SC, Herrero R, Franceschi SF, Ojeda JM.Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2271-6.
Branca M, Costa S, Mariani L, Sesti F,et al. Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study. Eur J Gynaecol Oncol. 2004;25(6):689-98.
Padilla-Paz La Human papillomavirus vaccine: history, immunology, current status, and future prospects. Clin Obstet Gynecol. 2005 Mar;48(1):226-40.
Ciotti M, Sesti F, Paba P, Benedetto A, Patrizi L, Criscuolo A, Piccione E, Branca M, Syrjanen K, Favalli C. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic. Eur J Gynaecol Oncol. 2004;25(5):577-84.
Tornesello ML, Duraturo ML, Salatiello I, Buonaguro L, Losito S, Botti G, Stellato G, Greggi S, Piccoli R, Pilotti S, Stefanon B, De Palo G, Franceschi S, Buonaguro FM. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol. 2004 Sep;74(1):117-26.
Harper DH et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004; 364: 1757-65
Franco EL, Harper DM Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine. 2005 Mar 18;23(17-18):2388-94
Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88:63-73.
Munoz N, Bosch FX, Castellsaguè X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004;111:278-285.
Durst M, Gissmann L, Ikenberg H, zur hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983;80:3812-5.
Arbyn M, Buntinx F, Van Ranst M, et al. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 2004;96:280-93.
Fife KH, Wheeler CM, Koutsky LA, et al. Dose-ranging studies of the safety and immunogenicity of human papillomavirus type 11 and type 16 virus-like particle candidate vaccines in young healthy women. Vaccine 2004;22:2943-52.
Ronco G, Ghisetti V, Segnan N, Snijders PJ, Gillio-Tos A, Meijer CJ, Merletti F, Franceschi S. Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer. 2005; 41(2):297-305.
Ciotti M, Sesti F, Paba P, Benedetto A, Patrizi L, Criscuolo A, Piccione E, Branca M, Syrjanen K, Favalli C. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic. Eur J Gynaecol Oncol. 2004; 25(5): 577-84.
Lehtinen M., Paavonen J. Vaccination against human papillomaviruses shows great promise. Lancet, 2004; 364: 1731-32.
Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet, 2004; 364: 1757-65
Black S, Shinefield H, Baxter R, Austrian R, Bracken L, Hansen J, Lewis E, Fireman B. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Infect Dis J. 2004 Jun;23(6):485-9.
Van Duynhoven YT, de Jager CM, Kortbeek LM, Vennema H, Koopmans MP, van Leusden F, van der Poel WH, van den Broek MJ. A one-year intensified study of outbreaks of gastroenteritis in The Netherlands. Epidemiol Infect. 133:9-21; 2005.
D’Ancona F. Epidemiologia delle forme invasive da pneumococco: esperienza dell’Istituto Sauperiore di Sanità. Attualità sull'epidemiologia e prevenzione delle infezioni da Streptococcus pneumoniae in età pediatrica. Roma, 8 Settembre 2003
Esposito S, Madore DV, Gironi S, Bosis S, Tosi S, Bianchi C, Cimino C, Principi N. Theoretic coverage of heptavalent pneumococcal conjugate vaccine in the prevention of community-acquired pneumonia in children in Italy. Vaccine. 2003 Jun 20;21:2704-7.
Pantosti A, D'Ambrosio F, Tarasi A, Recchia S, Orefici G, Mastrantonio P. Antibiotic susceptibility and serotype distribution of Streptococcus pneumoniae causing meningitis in Italy, 1997-1999.Clin Infect Dis 2000; 31:1373-9
Principi N. Impatto del pneumococco sulla morbosità infantile: nuove evidenze. Attualità sull'epidemiologia e prevenzione delle infezioni da Streptococcus pneumoniae in età pediatrica. Roma, 8 Settembre 2003
Romano G., Poli A., Chiamenti G ed il Gruppo di Lavoro EPNET. Infezioni invasive da pneumococco in età 0-36 mesi. Risultati di un’indagine longitudinale nel Triveneto. Attualità sull'epidemiologia e prevenzione delle infezioni da Streptococcus pneumoniae in età pediatrica. Roma, 8 Settembre 2003
Tancredi F. Studio policentrico sulle forme invasive da Streptococcus pneumoniae nei primi anni di vita. Attualità sull'epidemiologia e prevenzione delle infezioni da Streptococcus pneumoniae in età pediatrica. Roma, 8 Settembre 2003
Arista S, Vizzi E, Ferraro D, Cascio A. Di Stefano R. Distribution of VP7 serotypes and VP4 genotypes among rotavirus strains recovered from Italian children with diarrea. Arch Virol 142: 2065-2071; 1997.
Arista S, Giammanco GM, De Grazia S, Migliore MC, Martella V, Cascio A. Molecular characterisation of the genotype G9 human rotavirus strains recovered in Palermo, Italy, during the winter of 1999-2000. EpidemiolInfect 132. 343-349, 2004.
Banyai K, Gentsch JR, Griffin DD, Holmes JL, Glass RI, Szues G. Genetic variability among serotype G6 human rotaviruses: identification of a novel lineage isolated in Hungary. J Med Virol 71:124-134, 2003
Cascio A, Vizzi E, Alaimo C, Arista S. Rotavirus gastroenteritis in Italian children: can sevrity of symptoms be related to the infecting virus?. Clin Infect Dis 32: 1126-1132, 2001
Diwakarla S, Clark R, Palombo EA. Expanding distribution of human serotype G6 rotaviruses in Australia.Microbiol Immunol. 46:499-502, 2002.
Fischer TK, Eugen-Olsen J, Pedersen AG, Molbak K, Bottiger B, Rostgaard K, Nielsen NM. Characterization of rotavirus strains in a Danish population: high frequency of mixed infections and diversity within the VP4 gene of P[8] strains.
J Clin Microbiol. 43:1099-1104; 2005.
Gerna G, Sears J, Hishino Y, Steele AD, Nagakomi A, Sarasini A, Flores J. Identification of a new VP4 serotype of human rotaviruses. Virology 200: 66-71; 1994.

Parole Chiave

VACCINI; EPIDEMIOLOGIA; EPIDEMIOLOGIA MOLECOLARE; STRATEGIE VACCINALI; SANITA' PUBBLICA; PREVENZIONE